Contraceptive Options by Safety Level Hormonal IUD (Mirena, Kyleena) Copper IUD (Paragard) Implant (Nexplanon) Injectable (Depo-Provera) Barrier methods (condoms, diaphragm) Combined oral contraceptives Progestin-only pills (mini-pill) Vaginal ring (NuvaRing) Contraceptive patch Non-oral hormonal methods like the patch and ring may also be affected because they rely on consistent absorption patterns that GI changes can alter
The underreported symptoms are leads that came from patients themselves, unprompted, and clinicians could potentially pay attention to them. Commonly reported side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea, which have all been established in clinical trials and regulatory documents and have been extensively reported on
Retatrutide, the triple agonist GLP-1/GIP/glucagon receptor agonist, has its own reconstitution and storage requirements
Why GLP-1 Alone Isnt Enough While the real results of GLP-1 in 2025 are impressive, the limitations are clear: Dependence Stop taking the drug, and weight often returns
Microbial metabolites regulate GLP-1 secretion, while GLP-1RAs may reshape microbial composition and potentially amplify metabolic benefits
This is why simply drinking a glass of extra water often does not fix things